The importance of vaccination in achieving a positive trend in the prevention and treatment of paratyphs in the practice of infectious diseases.
Creators
- 1. Tashkent Scientific Research Institute of Vaccines and Serums.
Description
Although measures for the treatment of typhoid and paratyphoid, which are considered important and relevant in medical practice today, have been improved, the main measure to combat the disease is vaccination. This presented article provides an analysis of the importance, importance and relevance of the vaccine specifically in the prevention of typhoid and paratyphoid. And the main purpose of this presented work is to outline the importance of vaccination and a brief analysis of modern approaches to the prevention of typhoid and paratyphoid. To date, a number of research projects are underway to introduce various generations of vaccines into practice. However, no matter how high the activity of the vaccine is, it requires sufficient knowledge of the specifics of indications for use, contraindications to use and side effects. Thus, over the past hundred years, preventive vaccination has significantly reduced the incidence and mortality from infectious diseases worldwide. This process is regulated by the national schedule of routine vaccination in all countries. All children should be able to reach their full potential in health and well-being, and no child should die from preventable causes.
Files
819-827 N.N. Bakhramova.pdf
Files
(786.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:b6fabdce166c988c8a40eba971b2d759
|
786.3 kB | Preview Download |
Additional details
References
- 1. Shakya M, Neuzil KM, Pollard AJ. Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries. J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S770-S774. doi: 10.1093/infdis/jiab393
- 2. Sahastrabuddhe S, Saluja T. Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans. Clin Infect Dis. 2019 Feb 15;68(Suppl 1):S22-S26. doi: 10.1093/cid/ciy884.
- 3. Syed KA, Saluja T, Cho H, Hsiao A, Shaikh H, Wartel TA, Mogasale V, Lynch J, Kim JH, Excler JL, Sahastrabuddhe S. Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead. Clin Infect Dis. 2020 Jul 29;71(Suppl 2):S141-S150. doi: 10.1093/cid/ciaa504.
- 4. Dougan G, Baker S. Salmonella enterica serovar Typhi and the pathogenesis of typhoid fever. Annu Rev Microbiol 2014; 68:317–36.
- 5. Meiring JE, Laurens MB, Patel P, Patel P, Misiri T, Simiyu K, Mwakiseghile F, Tracy JK, Masesa C, Liang Y, Henrion M, Rotrosen E, Gmeiner M, Heyderman R, Kotloff K, Gordon MA, Neuzil KM. Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi. Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S50-S58. doi: 10.1093/cid/ciy1103.
- 6. Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials. Lancet Infect Dis. 2014 Feb;14(2):119-29. doi: 10.1016/S1473-3099(13)70241-X.
- 7. SAGE Working Group on Typhoid Vaccines and the WHO Secretariat. Background paper to SAGE on typhoid vaccine policy recommendations. Geneva, Switzerland: World Health Organization, 2017.
- 8. Намазова-Баранова Л. С., Федосеенко М. В., Баранов А. А. Новые горизонты Национального календаря профилактических прививок. Вопросы современной педиатрии. 2019; 18 (1): 13–30. doi: 10.15690/vsp.v18i1.1988)